Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 2, 2004, Pages 156-161

  Tagami, Keiko ^a   Niwa, Kenji ^a   Lian, Zenglin ^a   Gao, Jingchun ^a   Mori, Hideki ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Endometrial carcinogenesis; Juzen taiho to; Mouse; Prevention; Shimotsu to

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; ESTRADIOL; HERBACEOUS AGENT; ISOENZYME; JUZENTAIHOTO; MEMBRANE PROTEIN; MESSENGER RNA; METHYLNITROSOUREA; PTGS1 PROTEIN, MOUSE; SHIKUNSHI TO; SHIKUNSHI-TO; SHIMOTSU TO; SHIMOTSU-TO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; INCIDENCE; MOUSE; NONHUMAN; ONCOGENE C FOS; OVARIECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UTERUS; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHINESE MEDICINE; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; ISOENZYMES; MEDICINE, KAMPO; MEMBRANE PROTEINS; METHYLNITROSOUREA; MICE; MICE, INBRED ICR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 16544389311     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.156     Document Type: Article

References (37)

1. Onishi Y., Yamaura T., Tauchi K., Sakamoto T., Tsukada K., Nunome S., Komatsu Y., Saiki I., Biol. Pharm. Bull., 21, 761-765 (1998).
2. Kubota A., Okamura S., Shimoda K., Harada N., Omori F., Niho Y., Int. J. Immunother., 8, 191-195 (1992).
3. Hamada M., Fujiki Y., Yamamoto H., Miyazawa Y., Shui S. M., Tung Y. C., Yamaguchi N., J. Ethnopharma., 24, 311-320 (1991).
4. Maruyama H., Takemoto N., Maruyama N., Komatsu Y., Kawamura H., Int. J. Immunother., 9, 117-125 (1993).
5. Haranaka R., Hasegawa R., Nakagawa S., Sakurai A., Satomi N., Haranaka K., J. Biol. Response. Mod., 7, 77-90 (1988).
6. Sugiyama K., Ueda H., Ichiko Y., Yokota M., Biol. Pharm. Bull., 18, 53-58 (1995).
7. Saiki I., Biol. Pharm. Bull., 23, 677-688 (2000).
8. Adamson E. D., Development, 99, 449-471 (1987).
9. Weitz A., Bresciani F., Mol. Endocrionol., 2, 816-824 (1988).
10. Weatz A., Cicatiello L., Persiot E., Scalona M., Bresciani F., Mol. Endocrionol., 4, 1031-1050 (1990).
11. Niwa K., Murase T., Furui T., Morishita S., Mori H., Tanaka T., Mori H., Tamaya T., Jpn. J. Cancer Res., 84, 951-955 (1993).
12. Morishita S., Niwa K., Ichigo S., Hori M., Murase T., Fujimoto J., Tamaya T., Cancer Lett., 97, 225-231 (1995).
13. Niwa K., Morishita S., Hashimoto M., Itoh T., Fujimoto J., Mori H., Tamaya T., Jpn. J. Cancer Res., 89, 502-509 (1998).
14. Moore R. J., Owens D. M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M., Kollias G., Balkwill F., Nat. Med., 5, 828-831 (1999).
15. Okamoto M., Oyasu R., Lab. Invest., 7, 139-144 (1997).
16. Suganuma M., Okabe S., Marino M. W., Sakai A., Sueoka E., Fujiki H., Cancer Res., 59, 4516-4518 (1999).
17. Fujiki H., Suganuma M., Okabe S., Sueoka E., Suga K., Imai K., Nakachi K., Cancer Detect. Preven., 24, 91-99 (2000).
18. Komori A., Yatsunami J., Suganuma M., Okabe S., Abe S., Sakai A., Sasaki K., Fujiki H., Cancer Res., 53, 1982-1985 (1993).
19. Niwa K., Hashimoto M., Morishita S., Lian Z., Mori H., Tamaya T., Carcinogenesis, 22, 587-591 (2001).
20. Lian Z., Niwa K., Gao J., Tagami K., Hashimoto M., Yokoyama Y., Mori H., Tamaya T., Cancer Lett., 182, 19-26 (2002).
21. Hao X., Bishop A. E., Wallace M., Wang H., Willcocks T. C., Maclouf J., Polak J. M., Knight S., Talbot I. C., J. Pathol., 187, 295-301 (1999).
22. Fujita H., Koshida K., Keller E. T., Takahashi Y., Yoshimito T., Namiki M., Mizokami A., Prostate, 53, 232-240 (2002).
23. van Rees B. P., Saukkonen K., Ristimaki A., Polkowski W., Tytgat G. N., Drillenburg P., Offerhaus G. J., J. Pathol., 196, 171-179 (2002).
24. Costa C., Soares R., Reis-Filho J. S., Leitao D., Amendoeira I., Schmitt F. C., J. Clin. Pathol., 55, 429-434 (2002).
25. Ferrandina G., Legge F., Ranelletti F. O., Zannoni G. F., Maggiano N., Evangelisti A., Mancuso S., Scambia G., Lauriola L., Cancer, 95, 801-807 (2002).
26. Jabbour H. N., Milne S. A., Williams A. R., Anderson R. A., Bonddy S. C., Br. J. Cancer, 85, 1023-1031 (2001).
27. Chomczynski P., Sacchi N., Anal. Biochem., 162, 156-159 (1987).
28. Jang M., Pezzuto J. M., Cancer Lett., 134, 81-89 (1998).
29. Sabath D., Broome H. E., Prystowsky M. B., Gene, 91, 185-191 (1990).
30. Krajewska M., Krajewski S., Epstein J. I., Shabaik A., Sauvageot J., Song K., Kitada S., Reed J. C., Am. J. Pathol., 148, 1567-1576 (1996).
31. Fujiwaki R., Iida K., Kanasaki H., Ozaki T., Hata K., Miyazaki K., Hum. Pathol., 33, 213-219 (2002).
32. Scully R. E., Bonfiglio T. A., Kurman R. J., Silverberg S. G., Wilkinson E. J., "Histological Classification of Tumours of the Female Genital Tract," 2nd ed., eds. by Scully R. E., Bonfiglio T. A., Kurman R. J., Silverberg S. G., Wilkinson E. J., WHO, Geneva, 1994, pp. 13-18.
33. Yoshimi N., Sato S., Makita H., Wang A., Hirose Y., Tanaka T., Mori H., Carcinogenesis, 15, 783-785 (1994).
34. Charpigny G., Reinaud P., Creminon C., Tamby J. P., J. Reprod. Fertil., 117, 315-324 (1999).
35. Niwa K., Lian Z., Gao J., Tagami K., Tamaya T., Recent Prog. Kampo Med. Obstet. Gynecol., 19, 123-127 (2002) (in Japanese).
36. Shon Y. H., Kim J. H., Nam K. S., Biol. Pharm. Bull., 25, 77-80 (2002).
37. Kubo M., Ma S., Wu J., Matsuda H., Biol. Pharm. Bull., 19, 1041-1045 (1996).